Tavneos (avacopan) - Amgen
Rituxan (rituximab) - Roche
prednisone - Generic mfg.
Severe Small-Bowel Hemorrhage Preceding Pauci-Immune Crescentic Glomerulonephritis in PR3/c-ANCA-Associated Vasculitis (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0457; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Case Description A 60-year-old man developed a purpuric rash that improved with prednisone...Treatment with methylprednisolone and rituximab was initiated for active PR3-AAV...Avacopan was added but discontinued due to myalgias...Although renal disease is a classic feature of PR3-AAV, early kidney manifestations may be subtle despite active systemic vasculitis. Awareness of gastrointestinal manifestations is critical in atypical presentations of PR3-AAV to avoid delaying diagnosis and treatment." 
Acute Kidney Injury • ANCA Vasculitis • Glomerulonephritis • Hematological Disorders • Lupus Nephritis • Musculoskeletal Pain • Nephrology • Rare Diseases • Renal Disease • Vasculitis
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4556274
 
Clayton Brady; Jade Wexler; Upasana Agrawal; Vijayvardhan Kamalumpundi; Hatim A. Hassan; Cornelia Weyand
 
Oct 2, 2026
 
Prev Next